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It has long been known that intracellular cAMP inhibits and cGMP enhances intact
neutrophil function. However, these effects are modest and require relatively high
concentrations of the cyclic nucleotides. We decided to re-examine the effects of cyclic
nucleotides on Ca2-induced secretion by electroporated cells. This system allowed us to
bypass normal cell surface receptor-ligand interactions as well as to directly expose the
intracellular space to native cyclic nucleotides. We found that concentrations of cAMP as
low as 3 iM inhibited Ca2-induced secretion; 30-300 p.M cAMP was maximally inhibitory.
cAMP was actually slightly more potent than dibutyryl cAMP, a membrane-permeant
derivative. In contrast, cGMP was only slightly stimulatory at 3 p.M and modestly inhibitory
at 300 p.M; dibutyryl cGMP was ineffective. A more detailed investigation of the effects of
cAMP showed that inhibition was only obtained in the presence of Mg2. Half-maximal
inhibition by cAMP occurred at 10-30 M. Inhibition by cAMP was achieved by shifting the
Ca2 dose-response curve for secretion to the right; this was observed for the release of
both specific granules (vitamin B12 binding protein) and azurophil granules (B-glucuroni-
dase). We previously showed that ATP could enhance Ca2-induced secretion in the
presence of Mg2, apparently by interacting with a cell surface purine receptor. However,
increasing concentrations of ATP could not overcome inhibition by cAMP; this suggested
that cAMP acted at some site other than the purmne receptor. Inhibition by cAMP was also
less apparent in the presence of the protein kinase C agonist phorbol myristate acetate
(PMA), suggesting that the cyclic nucleotide did not produce systemic desensitization of
the neutrophils. In summary, these results demonstrate that low, physiologically relevant
concentrations of cAMP can modulate neutrophil responsiveness.
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INTRODUCTION
We and others have used a variety of means to render
neutrophil plasma membranes permeable for the pur-
poses of studying intracellular signal transduction. Neu-
trophils permeabilized with saponin and digitonin can be
induced to degranulate by exposure to Ca2 alone
[34,42,43]. Secretion from both specific and azurophil
granule can be elicited by Ca2 , with specific granules
being the more sensitive. A different method of perme-
abilizing neutrophils was pioneered by Grinstein and
Furuya [10], who used high voltage electric fields to
render human neutrophils permeable to molecules of
Mr< 700 Da. These investigators were thereby able to
introduce Ca-EGTA buffers and NADPH into the cytosol
and to stimulate 02 consumption by these cells following
exposure to surface stimuli; all experiments were done in
the presence of Mg-ATP. More recently, Nasmith et al.
[3 1] reported that a non-hydrolyzable guanine nude-
otide, GTP-’y-S, induces both 02 consumption and
tyrosine phosphorylation on its own. Activation of the
respiratory burst requires the presence of Mg24 and
ATP. Our own work showed that electroporated neutro-
phils secrete granule contents in response to increases in
Ca2 alone [41]. This degranulation is enhanced by
Mg2 and a wide variety of hydrolyzable and stable
nucleotide phosphates in the presence of Mg2 . The
nucleotides appear to be interacting with a non-specific
purine receptor which is coupled to protein kinase C.
Permeabilization also permits direct access of cyclic
nucleotides to the cytoplasmic space. These compounds
play a second messenger role in some cell types. Indeed,
exposure of neutrophils to phagocytizable particles re-
sults in a rapid (maximal within 15 sec) and brief
(returning to basal levels in 1-2 mm) doubling of cyclic
adenosine 3’,5’-monophosphate (cAMP) levels [12].
Stimulated increments in cAMP levels were later re-
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ported in rabbit [21] and human [11,13,28,30,36,40]
neutrophils. The observations that changes in cAMP
levels correlate closely with chemotaxis and degranula-
tion [30], display specific desensitization after repeated
exposures to the same stimulus, and that this desensiti-
zation is accompanied by a parallel decrease in superox-
ide (Ofl generation [35] suggest that changes in cyclic
nucleotide levels may be of mechanistic significance.
However, these observations are only correlative and a
number of lines of evidence suggest that changes in
cAMP are not important in stimulus-response coupling in
neutrophils. First, cAMP increases can be induced by
low concentrations of FMLP, without accompanying
degranulation or O generation [40], suggesting that the
former events are not sufficient for the latter. Second,
increments in cAMP do not appear to be necessary for
discharge of specific granules or O generation [30,44].
Finally, an inhibitor of adenylate cyclase, which blocks
the stimulated increase in cAMP, does not impair neu-
trophil responses [37] . These findings seem to rule out
cAMP in a second messenger role.
In spite of our previous report that cyclic nucleotides
have no effect upon secretion from saponin- or digitonin-
permeabilized neutrophils [42,43] and the evidence cited
above militating against a role for these compounds in
stimulus-response coupling, a number of factors per-
suaded us to re-examine the issue. The first was the
development of an electroporation system for permeabi-
lizing neutrophils, which proved to have substantially
different properties from those obtained using choles-
terol-complexing agents [4 1 ] ; this is likely related to the
sizes of the pores induced by the different techniques.
The second factor was a renewed interest in this area of
investigation: increments in cAMP have been linked to
calmodulin-dependent processes [20], the effects of cy-
clic nucleotides have been shown to be dependent upon
the stimulus employed [29,32,52] , and cAMP has been
shown to affect the functions of other permeabilized cell
types [4,22,47-49]. In the studies reported here, we
found that micromolar concentrations of cAMP inhibited
Ca2-induced secretion from electropermeabilized hu-
man neutrophils. This inhibition required Mg2 and




cAMP, cGMP, dibutyryl cAMP, dibutyryl cGMP,
ATP (adenosine 5 ‘-triphosphate), and phorbol myristate
acetate (PMA) were purchased from Sigma Chemical
Company (St. Louis, MO). [y-32P]-ATP was obtained
from Amersham (Arlington Heights, IL). K-252a was
purchased from Kamiya Biomedical Co. (Thousand
Oaks, CA). All chemicals for SDS-PAGE were electro-
phoresis grade, and all other materials were reagent
grade.
Preparation of Cell Suspensions
Heparmnized (10 units/mi) venous blood was obtained
from healthy adult donors. Purified preparations of
neutrophils were isolated from this blood by means of
Hypaque/Ficoll gradients [6] followed by standard tech-
niques of dextran sedimentation and hypotonic lysis of
erythrocytes [53] . This allowed studies of cell suspen-
sions containing 98 ± 2% neutrophils with few contam-
mating platelets or erythrocytes. The cells were washed
and finally suspended in a buffer consisting of 138 mM
NaC1, 2.7 mM KC1, 8.1 mM Na2HPO4, 1.5 mM
KH2PO4. For permeabilization studies, the cells were
instead washed once and resuspended in KC1-HEPES
buffer (100 mM KC1, 20 mM NaCl, 1 mM EGTA, and
30 mM HEPES, pH 7.0).
Neutrophil Permeabilization
Electropermeabilization was conducted essentially as
described by Grinstein and Furuya [ 10] with some
variations [41]. In essence, neutrophils were washed and
then resuspended in ice-cold KC1-HEPES buffer; Mg-
ATP and Ca2 were not included at this time. The cells,
at a concentration of 5 x i07 per ml, were transferred to
a chilled Biorad Pulsar cuvette and subjected to three
discharges of 5 kV/cm from a 25 iF capacitor (Biorad
Gene Pulsar) with gentle stirring between each pulse. The
capacitor discharged with a time constant of 0.5-0.7 ms
under these conditions. All permeabilization operations
were conducted at 4#{176}C.Viability, as assessed by trypan
blue exclusion, was consistently greater than 85%, in
accord with Grinstein and Furuya [10].
Lysosomal Enzyme Release
Following permeabilization, neutrophils were used
with or without washing, as indicated. Aliquots of the
ice-cold permeabilized cell suspensions (100 oil, contain-
ing 5 X 106 cells) were added to 900 il of pre-warmed
KC1-HEPES buffer containing the indicated additions
along with the desired concentration of free
Ca2 (determined for the buffer using a Ca2 electrode
[5]). The cells were then incubated at 37#{176}Cfor 7 mm;
cells incubated without Ca2 and intact neutrophils (in
KC1-HEPES buffer) were employed as routine controls.
The cell suspensions were then centrifuged at 750g for 10
mm. Aliquots of the supernatants were taken for standard
determinations of 3-glucuronidase [7] (an enzyme found
exclusively in azurophil granules), lysozyme [ 1] (an
enzyme found in both specific and azurophil granules),
and vitamin  2 binding protein [38] (a component of
specific granules alone).
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Electrophoresis and Autoradiography
Trichloroacetic acid precipitates from incubates with
[‘y-32P]-ATP and appropriate cofactors [45] were ex-
tracted in acetone, dried, and resuspended in sample
buffer (12.5% glycerol, 5% 3-mercaptoethanol, 2%
SDS, 62 mM Tris, pH 6.8, and 0.005% bromophenol
blue). The samples were sonicated and heated at 100#{176}C
for 5 mm before loading onto gels.
Electrophoresis was conducted using 10 or 12% mini-
slab gels (0.5 x 55 x 85 mm) or 10, 12, or 15% slab
gels (0.75 mm X 16 cm x 18 cm) and the discontinuous
buffer system of Laemmli [27]. Samples were loaded on
the mini-slab gels at approximately 5 X l0 cell equiv-
alents per lane and were electrophoresed at a constant
voltage of 180 V for 1 h at 4#{176}C.Samples were loaded at
a concentration of 2 x 106 cell equivalents per lane on
16 x 18 cm gels and electrophoresis was conducted at a
constant current of 15 mA for 3 h at room temperature.
All gels were stained with Coomassie Brilliant Blue.
Mini-gels were air dried between cellophane membrane
backing (BioRad), while 16 X 18 cm gels were dried
between cellophane membranes under vacuum at 80#{176}Con
a Biorad gel dryer. For autoradiographic analysis, gels
were exposed to X-Omat XAR-5 film at -70#{176}Cfor 1-10
days, with or without enlightening plus intensifying
screens.
RESULTS
We have previously shown that electroporated neutro-
phils can be induced to secrete lysosomal constituents in
response to micromolar levels of free Ca2 [41]. This
secretion is enhanced by Mg2 and several nucleotides
(in the presence of Mg2). In the course of these studies,
we found that micromolar concentrations of cAMP could
inhibit degranulation in this system. Figure 1 demon-
strates both the properties of Ca2tinduced secretion and
inhibition by cAMP. In the presence of Mg2 alone
(control), low concentrations of Ca2 evoked secretion
from specific granules, as indicated by the release of
vitamin B12 binding protein (upper left panel, open
circles). When 30 i.M cAMP was also present, degran-
ulation was inhibited over the entire range of Ca2
(squares; solid symbols indicate statistical significance
from corresponding control points). In the additional
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Fig. 1 . Effects of ATP and cAMP on Ca2-induced secretion
from electroporated human neutrophils. Human neutrophils
were permeabilized as detailed in “Materials and Methods” and
stimulated with the indicated concentrations of free Ca2 in the
presence of Mg2 (1 mM). Where relevant, the incubations also
included cAMP (30 p.M; square symbols) and ATP (300 tM). The
reaction mixtures were incubated for 7 minutes at 37#{176}Cand then
centrifuged. Release of vitamin B12 binding protein (top) and
B-glucuronidase (bottom) were measured in supernatant fluids.
The results are given as a percentage of control release, namely
that elicited by 30 iM Ca2 in the absence of cAMP; these
control release values were 49.9 ± 17.2% of total cellular vita-
mm B12 binding protein and 20.0 ± 4.0% B-glucuronidase. The
results shown are the means ± s.e.m. for four experiments.
Solid symbols denote those data points which were signifi-
cantly different (P < .05, paired Student t-test) from the absence
of added cAMP.
In an effort to get a more detailed description of
inhibition induced by cAMP, we varied the concentration
of the cyclic nucleotide in the presence and absence of
Mg2 and ATP, at a fixed (5 xM) Ca2 concentration.
Figure 3 (upper panel) shows that in the absence of
Mg2 or ATP (circles), cAMP had no effect. In the
presence of ATP alone (triangles), cAMP was only
slightly inhibitory. The lower panel shows that
Mg2 (squares) was required for inhibition by cAMP at
30 and 100 riM. When ATP was present along with
Mg2 (diamonds), significant inhibition by cAMP was
seen from 10 to 100 xM.
One possible model for our findings was that cAMP,
in the presence of Mg2 , was inhibiting the potentiation
by Mg2 of Ca2tinduced secretion. We therefore
wished to see if cAMP simply reversed the Mg2t
enhancement of secretion and returned it to the level
obtained with Ca2 alone. In experiments not shown, we
found that degranulation in the presence of cAMP and
Mg2 could be reduced below that obtained with
Ca2 alone. Thus, the data were not in accord with the
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protein was slightly increased; inhibition by cAMP was
still observed but was only statistically significant at 5
i.M Ca2 . A similar pattern was seen with secretion from
azurophil granules, as measured by B-glucuronidase
(lower panels), except that substantially more Ca2 was
required [4 11 . cAMP inhibited secretion from this gran-
ule type over most of the Ca2 dose range. The clearest
overall pattern was for vitamin 12 binding protein (upper
left panel), which encompassed a full dose-response
curve. In this case, the most pronounced effect of cAMP
was in the middle ranges, as the nucleotide appeared to
shift the Ca2 dose-response curve to the right.
We wished to see whether inhibition by cAMP was
unique to this nucleotide and whether permeant ana-
logues of the cyclic nucleotides had any greater effect.
For these experiments, we selected optimal conditions for
detection of inhibition of vitamin  2 binding protein
release by cAMP: i.e. , a mid-range Ca2 concentration
(5 riM) in the presence of the full secretory system
(Mg2 plus ATP). As shown in Figure 2, cAMP inhib-
ited secretion at concentrations as low as 3 iM (left set
of bars), with greater effect at 30 and 300 .tM. Dibutyryl
cAMP (dbcAMP), a membrane-permeant derivative, was
slightly less potent than cAMP itself; this is not unex-
pected since native cAMP should readily penetrate per-
meabilized cells and the larger dibutyryl derivative might
traverse the pores even more slowly. cGMP activated
degranulation only slightly at 3 riM; at high concentra-
tions, this nucleotide was actually inhibitory. The dibu-
tyryl derivative of cGMP had essentially no effect, with
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Fig. 2. Effects of various cyclic nucleotides on secretion of
vitamin B12 binding protein. Permeabilized neutrophils were
incubated with Ca2 (5 pM), Mg2 (1 mM), and ATP (300 i.M) in
the presence of 0, 3, 30, or 300 tM cAMP, dibutyryl cAMP
(dbcAMP), cyclic GMP (cGMP), or dibutyryl cGMP (dbcGMP), as
indicated. Vitamin B12 binding protein was assayed and release
is expressed as a percentage of that obtained with control cells
(absence of any nucleotide); this control value represented
21.2 ± 7.1% of the total cellular content (three experiments).
Asterisks indicate the level of significant differences from
control values (* < .05; ** < #{149}o, paired Student t-test).
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Fig. 3. Effects of various cAMP concentrations on secretion in
the presence and absence of Mg2 and ATP. Permeabilized
neutrophils were incubated with Ca2 (5 p.M) and the indicated
concentration of cAMP, with or without Mg2 (1 mM) or ATP (300
FM). Vitamin B12 binding protein was assayed and release Is
expressed as a percentage of that obtained with control cells
(absence of cAMP, presence of Mg-ATP); this control value
represented 29.2 ± 12.2% of the total cellular content (four
experiments). Solid symbols denote those data points which
were significantly different (P < .05, paired Student t-test) from
the absence of added cAMP.



























model cited above and cAMP thus was not simply an
antagonist for the action of Mg2 . In other control
experiments, we found that neither the phosphodiesterase
inhibitor theophylline nor the adenylate cyclase activator
PGE1 potentiated the action of cAMP (not shown). This
would be expected since in permeabilized, but not intact,
cells the cAMP level would be “clamped” by the
concentration present in the medium.
Because ATP appears to stimulate Ca2-induced Se-
cretion by interacting with a non-specific purine nude-
otide binding site [41], we wished to determine whether
cAMP also interacted with the same receptor. Unfortu-
nately, no specific inhibitor of this receptor has been
reported. Consequently, the most direct experiments we
could perform were to see if ATP itself could compete
with cAMP and overcome its inhibition. As shown in
Figure 4, increasing concentrations of ATP from 0 to
1 ,500 M produced little change in Ca2-induced secre-
tion in the absence of Mg2 (left set of bars). When
Mg2 was present (second set of bars), increasing con-
centrations of ATP produced greater degranulation. As
shown before, cAMP had no effect in the absence of
Mg2 (third set); however, in the presence of this diva-
lent cation (fourth set of bars), cAMP did inhibit ATP-
enhanced secretion, even in the presence of 1 ,500 .tM
nucleotide . The fact that high concentrations of ATP did
not counteract inhibition by cAMP indicated that the
cyclic nucleotide was interacting at a site other than that
utilized by ATP (presumably the purine receptor).
In order to see whether cAMP produced a systemic
desensitization of neutrophil secretion, we examined the
effects of this nucleotide on cells in which protein kinase
C (PKC) was stimulated by phorbol myristate acetate
(PMA). We have previously shown that PMA synergis-
tically enhances Ca2tinduced secretion from electropo-
rated neutrophils in the presence of Mg2 and Mg2t
ATP [41]; in this report, we showed that PMA reduces
the Ca2 requirement for half-maximal specific granule
secretion from 3 to 0.5 .tM. The upper panel of Figure 5
shows Ca2-induced release of vitamin B,, binding
protein; the left set of bars presents control data. It can be
seen that Mg2 and Mg2tATP (but not ATP alone)
increased degranulation stimulated by Ca2 , as expected.
This pattern was enhanced in the presence of PMA
(second set of bars). When cAMP (and Mg2) was
present, release of vitamin B12 binding protein was
strongly inhibited (compare the first and third sets of
bars). However, when PMA was also present, inhibition
by cAMP was much muted (compare second and fourth
set of bars). A similar pattern was also seen for the release
of B-glucuronidase (lower panel).












Fig. 4. Effect of ATP on inhibition by cAMP. Permeabilized
neutrophils were incubated with Ca2 (5 pM) and 30 M cAMP,
with or without Mg2 (1 mM) or the indicated concentrations of
ATP. Vitamin B12 binding protein was assayed and release is
expressed as a percentage of that obtained with control cells
(absence of cAMP, presence of 300 M Mg-ATP); this control
value represented 40.9 ± 7.0% of the total cellular content (three
experiments). Asterisks indicate the level of significant differ-




Fig. 5. Effect of PMA on inhibition by cAMP. Permeabilized
neutrophils were incubated with Ca2 (3.6 pM) and with or
without cAMP (30 pM), Mg2 (1 mM), ATP (300 pM), or PMA (10
ng/ml), as indicated. Vitamin B12 binding protein and B-glucu-
ronidase were assayed and release is expressed as a percent-
age of that obtained with control cells (absence of cAMP,
presence of PMA and 60 .M Ca2 ); this control value repre-
sented 34.1 ± I .4% of the total cellular content of vitamin B12
binding protein and 16.6 ± 1.7% of the total B-glucuronidase
(three experiments). Asterisks indicate samples which were
significantly different in the presence of cAMP (P < .05, paired
Student t-test).
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The most likely means by which cAMP inhibited
degranulation was by stimulating a cAMP-dependent
protein kinase (PKA). We were unable to overcome
cAMP inhibition using K-252a, an inhibitor of this kinase
(data not shown). This is probably because K-252a could
also inhibit protein kinase C, which is required for
ATP-enhanced secretion [41]. We also attempted to
determine the molecular target of the putative PKA.
Neutrophils were electroporated in the presence of [‘y-
32P]-ATP, either carrier-free or with 30 iM unlabeled
ATP, and then exposed to Ca2 , Mg2 , and cAMP under
conditions which inhibited secretion . Phosphorylated
proteins were analyzed by SDS-PAGE followed by
autoradiography. In essence, we were unable to find any
proteins which were specifically phosphorylated in the
presence of cAMP, with or without the divalent cations
(not shown).
DISCUSSION
It has long been known that agents which increase
intracellular cAMP levels reduce neutrophil responsive-
ness while those agents which increase cGMP concen-
trations enhance cellular functions [54]. The potential
importance of these second messengers is amplified by
the prompt production of cAMP following neutrophil
stimulation [12,36,40] and correlation of these incre-
ments with azurophil granule secretion [44]. While
stimulus-elicited increases in cGMP have been reported
[17-19], they have not been observed at early times by
others [36,40].
One of the difficulties in cyclic nucleotide research is
that the effects of these agents on neutrophil function are
quite modest. High concentrations of dibutyryl cAMP
(> 150 M) are often needed to obtain 20% inhibition of
degranulation and the putative stimulation obtained with
dibutyryl cGMP is often not evident [39]. Compounding
this problem is the fact that the effects of cyclic nude-
otides are dependent upon both the stimulus [20,29,
32,5 1 ,52] and the response [9,26] being examined. An
additional difficulty with most studies is that intracellular
cyclic nucleotide levels must be modulated either directly
by adding membrane-permeant derivatives or indirectly
by use of prostaglandins or beta-adrenergic agents.
However, with permeabilized cells, it is possible to
specifically introduce native cyclic nucleotides into the
cytoplasmic space in order to test their functions. This
model system bypasses cell surface receptors and the
individual signal transduction pathways initiated by spe-
cific stimuli. It was therefore gratifying to find that low
concentrations of cAMP (down to 3 pM) could inhibit
Ca2 -induced degranulation . Maximal inhibition re-
quired 30-100 pM cAMP and could reach 50%, sub-
stantially more than seen with intact cells. The data in
Figures 2-4 show that the amount of inhibition obtained
ranged from 25 to 60% , which is most attributable to the
variability normally seen in the responses of permeabi-
lized neutrophils [41]. cGMP did not stimulate degran-
ulation in this system; in fact, high concentrations of this
cyclic nucleotide inhibited responsiveness. Dibutyryl
cAMP was less effective than the native compound. This
is likely to be due to the larger size of the derivatized
agent which makes it comparable to the pore dimensions
of electropermeabilized neutrophils [10,411.
We also found that inhibition by cAMP required
Mg2 and was maximal when ATP was present. cAMP
shifted the Ca2 dose-response curve to the right and
appeared to antagonize the potentiation by Mg-ATP. The
requirement for Mg2 suggests two main possibilities for
the mechanism of action of cAMP. The first possibility is
that cAMP is somehow interacting with a recently
described cell surface purine nucleotide receptor [3,25].
This receptor binds a number of nucleotides, in addition
to ATP, in the presence of Mg2 and can lead to
enhancement of cellular function in intact [8] and per-
meabilized [41] cells. In permeabilized neutrophils, the
purine nucleotide apparently activates protein kinase C,
promoting degranulation [41]. In view of the broad
nucleotide specificity of this receptor, it was possible that
cAMP was binding to it as an inhibitor. However,
increasing concentrations of ATP did not antagonize the
effects of cAMP and so these two nucleotides were likely
to be operating at different sites.
A second possible mechanism for the action of cAMP,
which is consistent with the requirement for Mg2 , is the
activation of a cAMP-dependent protein kinase (PKA).
This enzyme has been isolated and characterized in
neutrophils [15,23,50] and a number of its acceptor
proteins determined [14]. More specifically, PKA can
phosphorylate a component of the NADPH oxidase [24]
and regulate a component in the platelet-activating factor
biosynthetic pathway [33]. However, in intact cells,
endogenous protein phosphorylation is not apparently
altered by dibutyryl cAMP [2], suggesting that cAMP-
dependent phosphorylation is only a fraction of the total
kinase activity. Furthermore, we have shown that phos-
phorylation of endogenous proteins in neutrophil ho-
mogenates is primarily dependent upon Mg2 , without a
requirement for other cofactors [45,46]. In view of this
high background from competing kinases, it is not
surprising that we were unable to detect any obvious
acceptors for PKA. It is possible that this enzyme is
phosphorylating some relatively rare component, such as
another enzyme, which mediates inhibition by cAMP.
While it is clear that increments in cAMP do not play
a positive effector role in signal transduction in neutro-
phils, it is also clear that they can play a modulatory role.
The studies reported here demonstrate that low, physio-
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logically relevant concentrations of cAMP can inhibit
secretion in a permeabilized model system in which
normal receptor-ligand interactions are bypassed. The
mechanism by which cAMP exerts its effects is un-
known. Our own data indicate that PKC activation can
overcome inhibition by cAMP (Fig. 5), suggesting that
the nucleotide acts proximal to PKC. Other potential
mechanisms were apparently excluded by Mueller and
Sklar [29], who published evidence that inhibition of
O7 generation by beta-adrenergic agonists (and, presum-
ably, cAMP) does not involve intracellular Ca2, the
activation of protein kinase C, or the activation of
G-proteins. Other reports indicate that inhibition by
cAMP appears to require Ca24 or calmodulin [20,32] but
does not involve perturbation of intracellular Ca2 levels
per se. Stimulated increases in endogenous cAMP also
appear to require Ca2 [5 1] and may be due to activation
of adenylate cyclase by endogenously produced adeno-
sine [16]. This close tie between cAMP and Ca2 can be
readily exploited by the permeabilized cell model and
future experiments will attempt to more precisely localize
the mode of action of this cyclic nucleotide.
ACKNOWLEDGMENTS
This work was supported by NIH grant DK3247 1
(J . E. S.).
REFERENCES
1 . Worthington Enzyme Manual 100, 1972.
2. Andrews, P.C. ,and Babior, B.M. Phosphorylation of cytosolic
proteins by resting and activated human neutrophils. Blood
64,883, 1984.
3. Axtell, R.A., Sandborg, R.R., Smolen, J.E., Ward, PA., and
Boxer, L.A. Exposure of human neutrophils to exogenous nude-
otides causes elevation in intracellular calcium, transmembrane
calcium fluxes. and an alteration of a cytosolic factor resulting in
enhanced superoxide production in response to FMLP and arachi-
donic acid. Blood 75,1324, 1990.
4. Baldys Waligorska A. , Pur, A. , Moriarty, CM. , and Dowd, F.
The effect of calcium and cyclic AMP on amylase release in
digitonin-permeabilized paratid gland cells. Biochim. Biophys.
Acta 929,190, 1987.
5. Bers, D.M. A simple method for the accurate determination of
free (Ca) in Ca-EGTA solutions. Am. J. Physiol. 242,C404,
1982.
6. Boyum, A. Isolation of mononuclear cells and granulocytes from
human blood. Isolation of mononuclear cells by centrifugation
and of granulocytes by combining centrifugation and sedimenta-
tion at I G. Scand. J. Clin. Lab. Invest. 21 ,77, 1968.
7. Brittinger, G.R. , Hirschborn, R. , Douglas, S.D. , and Weiss-
mann, G. Studies on lysosomes. XI. Characterization of hydro-
lase-rich fraction from human lymphocytes. J. Cell Biol. 37,394,
1968.
8. Cockcroft, S. , and Stutchfield, J. ATP stimulates secretion in
human neutrophils and HL6O cells via a pertussis toxin-sensitive
guanine nucleotide-binding protein coupled to phospholipase C.
FEBS Lett. 245,25, 1989.
9. De Togni, P. , Cabrini, G. , and Di Virgilio, F. Cyclic AMP
inhibition of fMet-Leu-Phe-dependent metabolic responses in
human neutrophils is not due to its effects on cytosolic Ca2’.
Biochem. J. , 224,269, 1984.
10. Grinstein, S. , and Furuya, W. Receptor-mediated activation of
electropermeabilized neutrophils. Evidence for a Ca2’- and
protein kinase C-independent signaling pathway. J. Biol. Chem.
263,1779, 1988.
1 1 . Herlin, T. , and Borregaard, N. Early changes in cyclic AMP and
calcium efflux during phagocytosis by neutrophils from normals
and patients with chronic granulomatous disease. Immunology
48,17, 1983.
12. Herlin, T. , Petersen, CS. , and Esmann, V. The role of calcium
and cyclic adenosine 3’ ,5’-monophosphate in the regulation of
glycogen metabolism in phagocytozing human polymorphonu-
clear leukocytes. Biochim. Biophys. Acta 542,63, 1978.
13. Hopkins, N.K. , Lin, A.H. , and Gorman, R.R. Evidence for
mediation of acetyl glyceryl ether phosphorylcholine stimulation
of adenosine 3’,5’-(cyclic)monophosphate levels in human poly-
morphonuclear leukocytes by leukotnene B. Biochim. Biophys.
Acta 763,276, 1983.
14. Huang, C.K. , Hill, J.M., Jr., Bormann, B.J., Mackin, W.M.,
and Becker, EL. Endogenous substrates for cyclic AMP-depen-
dent and calcium-dependent protein phosphorylation in rabbit
peritoneal neutrophils. Biochim. Biophys. Acta 760, 126, 1983.
15. Huang, C.K. , Mackin, W.M. , Bormann, B.J. , and Becker, EL.
Cyclic AMP receptor protein and cyclic AMP-dependent protein
kinase activity in rabbit peritoneal neutrophils. J. Reticuloendo-
thel. Soc. 34,413, 1983.
16. lannone, MA. , Wolberg, G. , and Zimmerman, T.P. Chemotactic
peptide induces cAMP elevation in human neutrophils by ampli-
fication of the adenylate cyclase response to endogenously pro-
duced adenosine. J. Biol. Chem. 264,20177, 1989.
17. Ignarro, L.J. , and George, W.J. Hormonal control of lysosomal
enzyme release from human neutrophils: elevation of cyclic
nucleotide levels by autonomic neurohormones. Proc. NatI. Acad.
Sci. U.S.A. 71,2027, 1974.
18. Ignarro, Li., and George, Wi. Mediation of immunologic
discharge of lysosomal enzymes from human neutrophils by
guanosine-3’ ,5 ‘ -monophosphate . Requirement of calcium, and
inhibition of adenosine-3’,5’-monophosphate. J. Exp. Med.
140,225, 1974.
19. Ignarro, L.J. , Lint, T.F. , and George, W.J. Hormonal control of
lysosomal enzyme release from human neutrophils. Effects of
autonomic agents on enzyme release, phagocytosis, and cyclic
nucleotide levels. J. Exp.Med. 139,1395, 1974.
20. Ishitoya, J. , and Takenawa, 1. Potentiation of PGE1-induced
increase in cyclic AMP by chemotactic peptide and
Ca2 ionophore through calmodulin-dependent processes. J. Im-
munol. 138,1201, 1987.
21 . Jackowski, S. , and Sha’afi, RI. Response of adenosine cyclic
3’ ,5’-monophophate level in rabbit neutrophils to the chemotactic
peptide formyl-methionyl-leucyl-phenylalanine. Mol. Pharmacol.
16,473, 1979.
22. Jones, P.M. , Salmon, D.M.W. , and Howell, S.L. Protein phos-
phorylation in electrically permeabilized islets of Langerhans:
Effects of Ca2 ,cyclic AMP, a phorbol ester and noradrenaline.
Biochem. J. 254,397, 1988.
23. JuhI, H. ,and Esmann, V. Purification and properties of cAMP
dependent and independent histone proteases from human leuko-
cytes. Mol. Cell. Biochem. 26,3, 1979.
24. Kramer, I.M. , van, der.Bend.R.L. ,Verhoeven, A.J. , and Roos,
D. The 47-kDa protein involved in the NADPH:O, oxidoreduc-
tase activity of human neutrophils is phosphorylated by cyclic
AMP-dependent protein kinase without induction of a respiratory
burst. Biochim. Biophys. Acta 971 , 189, 1988.
cAMP Inhibition of Permeabilized Neutrophils 179
25. Kuhns, D.B. , Wright, D.G. ,Nath, J. ,Kaplan, S.S. ,and Basford,
RE. AlP induces transient elevations of [Ca2’]i in human
neutrophils and primes these cells for enhanced O generation.
Lab. Invest. 58,448, 1988.
26. Lad, P.M. ,Goldberg, B.J. , Smiley, PA. , and Olson, CV.
Receptor-specific threshold effects of cyclic AMP are involved in
the regulation of enzyme release and superoxide production from
human neutrophils. Biochim. Biophys. Acta 846,286, 1985.
27. Laemmli, U.F. Cleavage ofstructural proteins during assembly of
the head of bacteriophage 14. Nature 227,680, 1970.
28. Marx, R.S. , McCall, CE. , and Bass, D.A. Chemotaxin-induced
changes in cyclic adenosine monophosphate levels in human
neutrophils. Infect. Immun. 29,284, 1980.
29. Mueller, H. , and SkIar, L.A. Coupling of antagonistic signalling
pathways in modulation of neutrophil function. J. Cell. Biochem.
40,287, 1989.
30. Naef, A. , Damerau, B. , and Keller, H.U. Relationship between
the transient cAMP increase, exocytosis from specific and azuro-
phil granules and chemotaxis in neutrophil granulocytes. Agents
Actions 14,63, 1984.
31. Nasmith, P.E., Mills, GB., and Grinstein, S. Guanine nude-
otides induce tyrosine phosphorylation and activation of the
respiratory burst in neutrophils. Biochem. J. 257,893, 1989.
32. Nielson, C.P. Beta adrenergic modulation of the polymorphonu-
clear leukocyte respiratory burst is dependent upon the mechanism
of cell activation. J. Immunol. 139,2392, 1987.
33. Nieto, ML. , Velasco, S. , and Sanchez Crespo, M. Modulation of
acetyl-CoA: 1-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-
PAF) acetyltransferase in human polymorphonuclears. The role of
cyclic AMP-dependent and phospholipid sensitive, calcium-de-
pendent protein kinases. J. Biol. Chem. 262,4607, 1988.
34. Prentki, M. , Wollheim, C.B. ,and Lew, PD. Ca2 homeostasis
in permeabilized human neutrophils. Characterization of Ca2’-
sequestering pools and the action of inositol 1 ,4,5-triphosphate. J.
Biol. Chem. 259,13777, 1984.
35. Simchowitz, L. , Atkinson, J.P. , and Spilberg, I. Stimulus-
dependent deactivation of chemotactic factor-induced cyclic AMP
response and superoxide generation by human neutrophils. J.
Clin. Invest. 66,736, 1980.
36. Simchowitz, L. , Fischbein, L.C. , Spilberg, I. , and Atkinson, J.P.
Induction of a transient elevation in intracellular levels of ade-
nosine-3’,5’-monophosphate by chemotactic factors: an early
event in human neutrophil activation. J. Immunol. 124,1482,
1980.
37. Simchowitz, L. ,Spilberg, I.,and Atkinson, J.P. Evidence that
the functional responses of human neutrophils occur indepen-
dently of transient elevations in cyclic AMP levels. J. Cyclic
Nucleotide Protein Phosphor. Res. 9,35, 1983.
38. Smith, G.P. , and Peters, T.J. The release of granule components
from human polymorphonuclear leukocytes in response to both
phagocytic and chemical stimuli. Biochim. Biophys. Acta 719,
304, 1982.
39. Smolen, J.E. The fluorescence response of chlortetracycline-
loaded human neutrophils is modulated by prostaglandin E1 , but
not by cyclic nucleotides. FEBS Lett. 163, I 19, 1983.
40. Smolen, J.E. , Korchak, H.M. , and Weissmann, G. Increased
levels of cyclic adenosine-3’,5’-monophosphate in human poly-
morphonuclear leukocytes after surface stimulation. J. Clin.
Invest. 65,1077, 1980.
41 . Smolen, J.E. , and Sandborg, R.R. Ca2-induced secretion by
electropermeabilized human neutrophils. The roles of Ca2,
nucleotides and protein kinase C. Biochim. Biophys. Acta
1052,133, 1990.
42. Smolen, J.E. , and Stoehr, Si. Micromolar concentrations of free
calcium provoke secretion of lysozyme from human neutrophils
permeabilized with saponin. J. Immunol. 134,1859, 1985.
43. Smolen, J.E. ,Stoehr, S.J. ,and Boxer, L.A. Human neutrophils
permeabilized with digitonin respond with lysosomal enzyme
release when exposed to micromolar levels of free calcium.
Biochim. Biophys. Acta 886, 1, 1986.
44. Smolen, J.E. , and Weissmann, G. Stimuli which provoke secre-
tion of azurophil granules induce increments in adenosine cyclic
3’,5’-monophosphate. Biochim. Biophys. Acta 672, 197, 1981.
45. Stoehr, S.J. , and Smolen, J.E. Human neutrophils contain a
protein kinase C which utilizes GTP as an alternate phosphate
donor. Cofactor requirements, kinetics, and endogenous acceptor
proteins. Blood 75,479, 1990.
46. Stoehr, S.J. , Smolen, J.E. , and Suchard, Si. Lipocortins are
major substrates for protein kinase C in extracts of human
neutrophils. J. Immunol. 144,3936, 1990.
47. Takuma, T. Evidence against direct involvement of cyclic AMP-
dependent protein phosphorylation in the exodytosis of amylase.
Biochem. J. 256.867, 1988.
48. Takuma, T. , and Ichida, 1. Amylase secretion from saponin-
permeabilized parotid cells evoked by cyclic AMP. J. Biochem.
(Tokyo) 103,95, 1988.
49. Tohmatsu, 1. . Nishida, A. , Nagao, S. ,Nakashima, S. , and
Nozawa, Y. Inhibitory action of cyclic AMP on inositol 1 ,4,5-
triphosphate-induced Ca2  release in saponin-permeabilized
platelets. Biochim. Biophys. Acta 1013,190, 1989.
50. Tsung, P.K. ,Sakamoto, T. ,and Weissmann, G. Protein kinase
and phosphatases from human polymorphonuclear leukocytes.
Biochem. J. 145,437, 1975.
51. Verghese, MW., Fox, K.. McPhail, L.C., and Snyderman, R.
Chemoattractant-elicited alterations of cAMP levels in human
polymorphonuclear leukocytes require a Ca2  -dependent mecha-
nism which is independent of transmembrane activation of ade-
nylate cyclase. J. Biol. Chem. 260,6769, 1985.
52. Wada, Y. Cyclic AMP inhibits chemotactic-peptide-induced but
not Ca2  -ionophore- or tetradecanoylphorbol-acetate-induced en-
zyme secretion in guinea pig neutrophils. Int. Arch. Allergy AppI.
Immunol. 90,194, 1989.
53. Zurier, RB. , Hoffstein, S. ,and Weissmann, G. Cytochalasin B:
effect on lysosomal enzyme release from human leukocytes. Proc.
Natl. Acad. Sci. U.S.A. 70,844, 1973.
54. Zurier, RB. , Weissmann, G. , Hoffstein, S. , Kammerman, S.,
and Tai, H.H. Mechanisms of lysosomal enzyme release from
human leukocytes. II. Effects of cAMP and cGMP, autonomic
agonists, and agents which affect microtubule function. J. Clin.
Invest. 53,297, 1974.
